This story originally ran on Nov. 18.
By Tony Fong
Despite a contraction in revenues related to its core technology, sample prep firm Pressure BioSciences this week reported a 19-percent increase in total revenues for the third quarter.
For the three months ended Sept. 30, the South Easton, Mass.-based company posted receipts of $317, 427, up from $265,662. Net loss for the quarter shrank 31 percent to $753,449, or $0.35 per share, from $1.1 million, or $0.50 per share, a year ago.